FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220764592> ?p ?o ?g. }

• W4220764592 abstract "Cefiderocol may represent a therapeutic option for carbapenem-resistant Acinetobacter baumannii (CRAB) infections, but clinical data are limited. This is an observational retrospective study conducted in the University Hospital of Pisa including consecutive patients with CRAB infections (January 2020 to August 2021). Patients were divided in two study groups according to the antibiotic treatment received: cefiderocol- and colistin-containing regimens. The primary outcome was the 30-day mortality. A Cox regression analysis was performed to identify factors independently associated with 30-day mortality. A propensity score analysis using inverse probability of treatment weighting (IPTW) was also performed. A total of 124 patients were included: 47 (37.9%) received cefiderocol, while 77 (62.1%) colistin-containing regimens. Overall, 79 (63.7%) patients had a bloodstream infection (BSI), 35 (28.5%) a ventilator-associated pneumonia (VAP) and 10 (8.1%) other infections. Thirty-day mortality was higher in patients receiving colistin- compared to those who received cefiderocol-containing regimens (55.8% versus 34%, P = 0.018). This difference was confirmed in patients with BSI, but not in those with VAP. On multivariable analysis, septic shock, SOFA score, and age were independently associated with 30-day mortality, while cefiderocol therapy was protective in an IPTW analysis (Hazard ratio 0.44, 95% confidence interval 0.22-0.66, P < 0.001). Nephrotoxicity was more common in the colistin group. Microbiological failure occurred in 17.4% of patients receiving cefiderocol versus 6.8% of those receiving colistin (P = 0.079). Among 8 cases in the cefiderocol group who experienced microbiological failure, 4 (50%) developed resistance to cefiderocol. Cefiderocol represents a promising therapeutic option in patients with severe CRAB infections. Randomized clinical trial in this specific patient population should confirm our findings." @default.
• W4220764592 created "2022-04-03" @default.
• W4220764592 creator A5015013063 @default.
• W4220764592 creator A5029272832 @default.
• W4220764592 creator A5038660145 @default.
• W4220764592 creator A5044157939 @default.
• W4220764592 creator A5048088023 @default.
• W4220764592 creator A5052274037 @default.
• W4220764592 creator A5068115673 @default.
• W4220764592 creator A5090841446 @default.
• W4220764592 date "2022-05-17" @default.
• W4220764592 modified "2023-10-14" @default.
• W4220764592 title "Cefiderocol- Compared to Colistin-Based Regimens for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii" @default.
• W4220764592 cites W1777851592 @default.
• W4220764592 cites W1984297262 @default.
• W4220764592 cites W2026274122 @default.
• W4220764592 cites W2036224327 @default.
• W4220764592 cites W2036496398 @default.
• W4220764592 cites W2060316606 @default.
• W4220764592 cites W2104747240 @default.
• W4220764592 cites W2110818436 @default.
• W4220764592 cites W2151069359 @default.
• W4220764592 cites W2164273263 @default.
• W4220764592 cites W2178527956 @default.
• W4220764592 cites W2198013734 @default.
• W4220764592 cites W2605062914 @default.
• W4220764592 cites W2766023307 @default.
• W4220764592 cites W2786314763 @default.
• W4220764592 cites W2797160634 @default.
• W4220764592 cites W2936039267 @default.
• W4220764592 cites W2951981149 @default.
• W4220764592 cites W3003721827 @default.
• W4220764592 cites W3026777707 @default.
• W4220764592 cites W3033526748 @default.
• W4220764592 cites W3082652924 @default.
• W4220764592 cites W3087097003 @default.
• W4220764592 cites W3092383626 @default.
• W4220764592 cites W3115438532 @default.
• W4220764592 cites W3157613645 @default.
• W4220764592 cites W3165004308 @default.
• W4220764592 cites W3174970615 @default.
• W4220764592 cites W3175792336 @default.
• W4220764592 cites W3179914052 @default.
• W4220764592 cites W3181221663 @default.
• W4220764592 cites W3190303490 @default.
• W4220764592 doi "https://doi.org/10.1128/aac.02142-21" @default.
• W4220764592 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35311522" @default.
• W4220764592 hasPublicationYear "2022" @default.
• W4220764592 type Work @default.
• W4220764592 citedByCount "72" @default.
• W4220764592 countsByYear W42207645922022 @default.
• W4220764592 countsByYear W42207645922023 @default.
• W4220764592 crossrefType "journal-article" @default.
• W4220764592 hasAuthorship W4220764592A5015013063 @default.
• W4220764592 hasAuthorship W4220764592A5029272832 @default.
• W4220764592 hasAuthorship W4220764592A5038660145 @default.
• W4220764592 hasAuthorship W4220764592A5044157939 @default.
• W4220764592 hasAuthorship W4220764592A5048088023 @default.
• W4220764592 hasAuthorship W4220764592A5052274037 @default.
• W4220764592 hasAuthorship W4220764592A5068115673 @default.
• W4220764592 hasAuthorship W4220764592A5090841446 @default.
• W4220764592 hasBestOaLocation W42207645922 @default.
• W4220764592 hasConcept C126322002 @default.
• W4220764592 hasConcept C177713679 @default.
• W4220764592 hasConcept C207103383 @default.
• W4220764592 hasConcept C2776315533 @default.
• W4220764592 hasConcept C2776685102 @default.
• W4220764592 hasConcept C2777628635 @default.
• W4220764592 hasConcept C2777637488 @default.
• W4220764592 hasConcept C2777914695 @default.
• W4220764592 hasConcept C2778384902 @default.
• W4220764592 hasConcept C2779259085 @default.
• W4220764592 hasConcept C2780675486 @default.
• W4220764592 hasConcept C44249647 @default.
• W4220764592 hasConcept C501593827 @default.
• W4220764592 hasConcept C523546767 @default.
• W4220764592 hasConcept C54355233 @default.
• W4220764592 hasConcept C71924100 @default.
• W4220764592 hasConcept C86803240 @default.
• W4220764592 hasConcept C89423630 @default.
• W4220764592 hasConceptScore W4220764592C126322002 @default.
• W4220764592 hasConceptScore W4220764592C177713679 @default.
• W4220764592 hasConceptScore W4220764592C207103383 @default.
• W4220764592 hasConceptScore W4220764592C2776315533 @default.
• W4220764592 hasConceptScore W4220764592C2776685102 @default.
• W4220764592 hasConceptScore W4220764592C2777628635 @default.
• W4220764592 hasConceptScore W4220764592C2777637488 @default.
• W4220764592 hasConceptScore W4220764592C2777914695 @default.
• W4220764592 hasConceptScore W4220764592C2778384902 @default.
• W4220764592 hasConceptScore W4220764592C2779259085 @default.
• W4220764592 hasConceptScore W4220764592C2780675486 @default.
• W4220764592 hasConceptScore W4220764592C44249647 @default.
• W4220764592 hasConceptScore W4220764592C501593827 @default.
• W4220764592 hasConceptScore W4220764592C523546767 @default.
• W4220764592 hasConceptScore W4220764592C54355233 @default.
• W4220764592 hasConceptScore W4220764592C71924100 @default.
• W4220764592 hasConceptScore W4220764592C86803240 @default.
• W4220764592 hasConceptScore W4220764592C89423630 @default.
• W4220764592 hasIssue "5" @default.
• W4220764592 hasLocation W42207645921 @default.

• next